---
figid: PMC7767049__cancers-12-03853-g002
figlink: pmc/articles/PMC7767049/figure/cancers-12-03853-f002/
number: F2
caption: 'Administration of β-AR blockade can enhance the efficacy of RT by modulation
  of tumor microenvironment in irradiated and non-irradiated tumors. 1. For irradiated
  tumors: β-blocker (a) suppresses proliferation and induces apoptosis via modulation
  of cell cycle. (b) suppresses neuroendocrine differentiation by blocking cAMP/PKA/CREB
  pathway and inhibits the conversion of prorenin to renin and downregulates RAS which
  is required for cancer stem cell maintenance and differentiation. (c) inhibits HIF-1α
  mediated angiogenesis and LYPD3 induced metastasis, and mitochondrial and glucose
  metabolism in cancer cells. 2. For non-irradiated tumors: β-blocker (d) enhances
  trafficking of effector T-cells by upregulation of CXCR3 and its ligands CXCL9,
  CXCL10 to the non-irradiated tumor, (e) improves expression of IFNγ, TNFα, GzmB
  and T-bet, leading to infiltration of effector T-cells and effective elimination
  of tumor cells in the non-irradiated tumor, (f) decreases the number and immunosuppressive
  function of tumor-associated macrophages, MDSCs and regulatory T-cells, and effectively
  overcomes tumor immunosuppression.'
pmcid: PMC7767049
papertitle: Highlighting the Potential for Chronic Stress to Minimize Therapeutic
  Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.
reftext: Minhui Chen, et al. Cancers (Basel). 2020 Dec;12(12):3853.
pmc_ranked_result_index: '10444'
pathway_score: 0.9054617
filename: cancers-12-03853-g002.jpg
figtitle: Administration of Beta-AR blockade can enhance the efficacy of RT by modulation
  of tumor microenvironment in irradiated and non-irradiated tumors
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7767049__cancers-12-03853-g002.html
  '@type': Dataset
  description: 'Administration of β-AR blockade can enhance the efficacy of RT by
    modulation of tumor microenvironment in irradiated and non-irradiated tumors.
    1. For irradiated tumors: β-blocker (a) suppresses proliferation and induces apoptosis
    via modulation of cell cycle. (b) suppresses neuroendocrine differentiation by
    blocking cAMP/PKA/CREB pathway and inhibits the conversion of prorenin to renin
    and downregulates RAS which is required for cancer stem cell maintenance and differentiation.
    (c) inhibits HIF-1α mediated angiogenesis and LYPD3 induced metastasis, and mitochondrial
    and glucose metabolism in cancer cells. 2. For non-irradiated tumors: β-blocker
    (d) enhances trafficking of effector T-cells by upregulation of CXCR3 and its
    ligands CXCL9, CXCL10 to the non-irradiated tumor, (e) improves expression of
    IFNγ, TNFα, GzmB and T-bet, leading to infiltration of effector T-cells and effective
    elimination of tumor cells in the non-irradiated tumor, (f) decreases the number
    and immunosuppressive function of tumor-associated macrophages, MDSCs and regulatory
    T-cells, and effectively overcomes tumor immunosuppression.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCN10A
  - TBX21
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - HRAS
  - KRAS
  - NRAS
  - LYPD3
  - HK2
  - IFNG
  - TNF
  - GZMB
  - CXCL9
  - CXCL10
  - CXCR3
  - glucose
  - O
  - tumor
  - metastases
  - cancer
genes:
- word: SNS
  symbol: SNS
  source: hgnc_alias_symbol
  hgnc_symbol: SCN10A
  entrez: '6336'
- word: T-bet
  symbol: T-bet
  source: hgnc_alias_symbol
  hgnc_symbol: TBX21
  entrez: '30009'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: T-bet
  symbol: T-bet
  source: hgnc_alias_symbol
  hgnc_symbol: TBX21
  entrez: '30009'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: LYPD3
  symbol: LYPD3
  source: hgnc_symbol
  hgnc_symbol: LYPD3
  entrez: '27076'
- word: (HK2
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: GzmB
  symbol: GZMB
  source: hgnc_symbol
  hgnc_symbol: GZMB
  entrez: '3002'
- word: CXCL9
  symbol: CXCL9
  source: hgnc_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: CXCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: CXCR3
  symbol: CXCR3
  source: hgnc_symbol
  hgnc_symbol: CXCR3
  entrez: '2833'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: tumor
  source: MESH
  identifier: D009369
- word: metastases
  source: MESH
  identifier: D009362
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7767049__F2
redirect_from: /figures/PMC7767049__F2
figtype: Figure
---
